|
May 24
|
OpGen Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q
|
|
Aug 10
|
OpGen Reports Second Quarter 2023 Financial Results and Provides Business Update
|
|
Aug 7
|
OpGen’s Subsidiary Ares Genetics Releases New Features to its AREScloud Offering
|
|
Apr 26
|
OpGen’s Subsidiary Curetis Meets All Remaining Key Milestones in R&D Collaboration with FIND
|